BORASCHI, DIANA
 Distribuzione geografica
Continente #
AS - Asia 2.374
NA - Nord America 1.226
EU - Europa 480
SA - Sud America 445
AF - Africa 49
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.577
Nazione #
US - Stati Uniti d'America 1.158
SG - Singapore 1.084
CN - Cina 474
BR - Brasile 362
HK - Hong Kong 289
VN - Vietnam 260
FR - Francia 147
IT - Italia 102
KR - Corea 79
FI - Finlandia 47
JP - Giappone 45
DE - Germania 44
IN - India 38
NL - Olanda 35
CA - Canada 30
GB - Regno Unito 29
AR - Argentina 23
MX - Messico 18
IL - Israele 15
BD - Bangladesh 14
EC - Ecuador 14
CO - Colombia 12
PL - Polonia 12
ID - Indonesia 11
MA - Marocco 11
TR - Turchia 11
SA - Arabia Saudita 10
AT - Austria 9
CL - Cile 9
EG - Egitto 8
ES - Italia 8
LT - Lituania 8
PE - Perù 8
ZA - Sudafrica 8
UZ - Uzbekistan 7
IE - Irlanda 6
KE - Kenya 6
TN - Tunisia 6
UA - Ucraina 6
VE - Venezuela 6
IQ - Iraq 5
KZ - Kazakistan 5
NP - Nepal 5
PA - Panama 5
PK - Pakistan 4
PY - Paraguay 4
SE - Svezia 4
UY - Uruguay 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
MY - Malesia 3
RS - Serbia 3
SN - Senegal 3
BO - Bolivia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 4.577
Città #
Singapore 642
Santa Clara 459
Hong Kong 288
Hefei 193
San Jose 155
Lauterbourg 116
Beijing 95
Ashburn 86
Ho Chi Minh City 86
Hanoi 81
Seoul 78
Dallas 61
Los Angeles 47
Tokyo 32
São Paulo 31
Helsinki 26
New York 25
Frankfurt am Main 19
Milan 19
Buffalo 16
Council Bluffs 14
Lappeenranta 13
Marigliano 12
Rio de Janeiro 12
Minamishinagawa 11
Da Nang 10
Orem 10
Campinas 9
Chennai 9
Nuremberg 9
Porto Alegre 9
Brasília 8
London 8
Montreal 8
Phoenix 8
Turku 8
Warsaw 8
Brooklyn 7
Cairo 7
Chicago 7
Haiphong 7
Naples 7
Tashkent 7
Belo Horizonte 6
Guayaquil 6
Hải Dương 6
Ribeirão Preto 6
Atlanta 5
Bengaluru 5
Biên Hòa 5
Changsha 5
Falkenstein 5
Lima 5
Nairobi 5
Nha Trang 5
Nova Iguaçu 5
Riyadh 5
Rome 5
São Gonçalo 5
Thái Nguyên 5
Toronto 5
Bauru 4
Brescia 4
Campo Grande 4
Casablanca 4
Curitiba 4
Denver 4
Dhaka 4
Dublin 4
Guarulhos 4
Istanbul 4
Jeddah 4
Marília 4
Medellín 4
Medford 4
Montevideo 4
New Delhi 4
Osasco 4
Portsmouth 4
Potenza 4
Quận Một 4
Santo André 4
São Bernardo do Campo 4
Vienna 4
Amsterdam 3
Araguari 3
Asunción 3
Avellino 3
Baghdad 3
Boston 3
Calgary 3
Can Tho 3
Caracas 3
Dakar 3
Duque de Caxias 3
Houston 3
Johannesburg 3
Juiz de Fora 3
Lases 3
Miami 3
Totale 2.997
Nome #
Engineered nanoparticles. How brain friendly is this new guest? 104
Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding 100
Towards bio-compatible magnetic nanoparticles Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance 82
Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living Species 73
Profiling the Course of Resolving vs. Persistent Inflammation in Human Monocytes: The Role of IL-1 Family Molecules 71
Regulation of innate receptors and IL-18 in hepatocytic cells is altered by environmental particles. 67
Endotoxin contamination: a key element in the interpretation of nanosafety studies 67
Probing the immune responses to nanoparticles across environmental species. A perspective of the EU Horizon 2020 project PANDORA 67
Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans 67
IL-1 Family 65
Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True 64
Innate and germline immune memory: specificity and heritability of the ancient immune mechanisms for adaptation and survival 62
Direct LC-MS/MS Analysis of Extra- and Intracellular Glycerophosphoinositol in Model Cancer Cell Lines 61
Structural disconnectivity in postoperative delirium: A perioperative two-center cohort study in older patients 60
Innate Memory Reprogramming by Gold Nanoparticles Depends on the Microbial Agents That Induce Memory 60
Effects of nano-and microplastics in the development of immune memory in the ascidian Ciona robusta 58
Personalised Profiling of Innate Immune Memory Induced by Nano-Imaging Particles in Human Monocytes 57
Development of biologicals for the therapy of lupus erythematosus 56
Interaction between nanomaterials and the innate immune system across evolution 56
Environmental stress and nanoplastics' effects on Ciona robusta: regulation of immune/stress-related genes and induction of innate memory in pharynx and gut 56
Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? 52
New approaches to anti-bacterial mucosal immunization through targeted modulation of innate immunity mechanisms 51
ImmuNapoli 2019 51
Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice 49
Primary and memory response of human monocytes to vaccines: Role of nanoparticulate antigens in inducing innate memory 49
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses 49
Suitability of in vitro Immunotoxicity Methods for Assesment of Nanomaterials 48
Poverty-Related Disease College: a virtual African-European network to build research capacity. 46
Interaction between Macrophages and Nanoparticles: In Vitro 3D Cultures for the Realistic Assessment of Inflammatory Activation and Modulation of Innate Memory 45
Concern-driven integrated approaches to nanomaterial testing and assessment - report of the NanoSafety Cluster Working Group 10 44
The association between frailty and MRI features of cerebral small vessel disease 43
Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles 43
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii 42
Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media 42
Cerebral microbleeds are not associated with postoperative delirium and postoperative cognitive dysfunction in older individuals 42
IL-1 family nomenclature 41
The IL-1 family cytokines and receptors in autoimmune diseases 41
Induction of Innate Immune Memory by Engineered Nanoparticles in Monocytes/Macrophages: From Hypothesis to Reality 40
Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal 39
Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes. 36
Cytokines and soluble receptors of the IL-1 family in Schnitzler syndrome. 35
Induction of long-term immunity against Respiratory Syncytial Virus glycoprotein by an osmotic polymer nanocarrier 35
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 35
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 34
The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria 34
Assessing Immunological Memory in the Solitary Ascidian Ciona robusta 32
Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro 32
Innate Immune Memory: The Latest Frontier of Adjuvanticity 32
From monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation 31
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 31
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 31
Preface 30
Chimeric plant virus particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice 30
Concepts for nano-delivery of therapeutic immunomodulatory agents 29
Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific 29
Nanoparticles and innate immunity: new perspectives on host defence. 29
Balance between autocrine IL-1² and caspases defines life vs. death of PMN 28
Nano-immunosafety: approaches to in vitro assessment 28
IL-37: a new anti-inflammatory cytokine of the IL-1 family 28
Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results 28
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 28
Nanoparticles and the immune system: safety and effects 28
Perspectives in immunopharmacology: The future of immunosuppression 28
From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology. 28
Vaccines of the Future: The Role of Inflammation and Adjuvanticity 28
Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease? 28
Modulation of defence cell functions by nano-particles in vitro. 27
IL-1 family nomenclature (vol 11, pg 973, 2010) 27
IL-1 family cytokines and receptors in IgG4-related disease. 27
ImmuNapoli 2016 27
Cytokine gene transfer in the therapy of autoimmune diseases 27
Exploring the interaction of nanomedicines with the human immune system, Assessing immunosafety and investigating preventive/therapeutic targeting. 26
Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain 25
Towards nanotechnology regulation-Publish the unpublishable 25
Assessing immunosafety of nanomaterials. Cell-based modelling of inflammatory responses to predict putative risks for human health 25
Pharmacological strategies using biologics as immunomodulatory agents 25
Specific immune response to HBsAg is enhanced by ²-glucan oligosaccharide containing an ±-(1 3)-linked bond, and biased towards M2/Th2 25
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria 25
Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms 24
How Innate and Adaptive Immunity Work 24
IL-1 family cytokines and monocytes/macrophages in the regulation of inflammation. 24
THE PATHOLOGICAL ROLE OF IL-18 IN LYMPHOID ORGANS OF AUTOIMMUNE MRL lpr/lpr MICE 24
Glycosylation enhances functional stability of the chemotactic cytokine CCL-2. 24
The need for addressing immunisafety of nanomaterials 24
Modulation of macrophage activation programming during inflammation. Integrated profiling in an in vitro model of human monocyte reactivity 24
REGULATION OF IL-1/IL-18 FAMILY CYTOKINES AND RECEPTORS BY ²-GLUCANS: PROMOTION OF NON-INFLAMMATORY RESPONSES IN EPITHELIAL CELLS AND MONOCYTES 24
Innate Reactivity of Intestinal Mucosal Cells: Regulation of the Expression of IL-1², IL-18 and TIR8/SIGIRR Genes by Engineered Nanoparticles 24
The immunostimulatory effect of IL-1 beta in vivo is blocked by antisense peptides complementary to the loop sequence 163-171 24
Immunosenescence and vaccine failure in the elderly: Strategies for improving response 23
Modulation of defence cell functions by nano-particles in vitro 23
Innate immune memory: Time for adopting a correct terminology 23
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. 23
Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1²/IL-1RI complex 23
ROLE OF IL-18 IN ONSET AND PROGRESSION OF AUTOIMMUNE LUPUS 23
UPREGULATION OF IL-1/IL-18 FAMILY CYTOKINES AND RECEPTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS 23
The Interleukin- 1 Family Cytokines and Receptors in Schnitzler-s Syndrome 23
Nanoparticles and the Immune System: Safety and Effects 23
The Gracefully Aging Immune System 22
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria 22
The problem of nanosafety: how to assess the fate of nano-bio interaction and predict risk. 22
Totale 3.859
Categoria #
all - tutte 15.572
article - articoli 10.389
book - libri 260
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.004
Totale 28.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 0 0 0 0 0 0 0 12 8 22 17
2024/20251.875 4 7 140 81 468 45 50 68 77 55 472 408
2025/20262.772 125 282 314 494 526 77 403 159 160 187 45 0
Totale 4.706